Pulsatile Ocular Blood Flow Study: Decreases in Exudative Age Related Macular Degeneration
Overview
Affiliations
Background: Pulsatile ocular blood flow (POBF) is a parameter for evaluating choroidal blood flow. POBF in the patients with non-exudative and exudative age related macular degeneration (AMD) was investigated.
Methods: POBF, pulse amplitude (PA), systolic and diastolic blood pressures, intraocular pressure (IOP), refractive error, and axial length were compared among 10 patients with non-exudative AMD, 11 patients with exudative AMD, and 69 age matched controls. A Langham OBF computerised tonometer was used with the participants in the sitting position to measure POBF and PA.
Results: No significant differences were found in age, systolic and diastolic blood pressures, IOP, or refractive error between patients with exudative and non-exudative AMD and the control subjects. In the patients with exudative AMD the POBF (median, 372.7 microl/min) and PA (median, 1.2 mm Hg) were significantly lower than in the patients with non-exudative AMD (median, 607.0 microl/min (p = 0.02) and 2.2 mm Hg (p = 0.04), respectively) and control subjects (median, 547.4 microl/min (p = 0.01) and 2.0 mm Hg (p = 0.01), respectively).
Conclusions: These data show that the POBF and PA in the patients with exudative AMD are lower than in the patients with non-exudative AMD and normal subjects. Decreased choroidal blood flow may have a role in the development of choroidal neovascularisation in AMD.
Deng Y, Qiao L, Du M, Qu C, Wan L, Li J Genes Dis. 2022; 9(1):62-79.
PMID: 35005108 PMC: 8720701. DOI: 10.1016/j.gendis.2021.02.009.
Danielewska M, Messner A, Werkmeister R, Placek M, Aranha Dos Santos V, Rekas M Transl Vis Sci Technol. 2019; 8(4):15.
PMID: 31388467 PMC: 6675519. DOI: 10.1167/tvst.8.4.15.
Choroidal Blood Flow Change in Eyes with High Myopia.
Yang Y, Koh J Korean J Ophthalmol. 2015; 29(5):309-14.
PMID: 26457036 PMC: 4595256. DOI: 10.3341/kjo.2015.29.5.309.
Ocular pulse amplitude and retinal vessel caliber changes after intravitreal ranibizumab.
Pekel G, Acer S, Cetin E, Yagci R, Kasikci A, Cevik A Int Ophthalmol. 2014; 35(5):657-62.
PMID: 25186317 DOI: 10.1007/s10792-014-9991-z.
Gewaily D, Grunwald J, Pistilli M, Ying G, Maguire M, Daniel E Am J Ophthalmol. 2014; 158(3):525-31.e2.
PMID: 24949820 PMC: 4458330. DOI: 10.1016/j.ajo.2014.06.004.